UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 8, 2023
Accession Number:
0001193125-23-058265
Submission Type:
POS AM
CIK:
0001322505
Company Name:
ALBIREO PHARMA, INC.
File Number:
333-266893